Google
Trusted Resources: News & Events
Latest announcements and gatherings
Greenville program tries team approach to improve lifespan of sickle cell disease patients
Dr. Alan Anderson who was involved with several pediatric sickle cell disease and cancer projects at hospitals in Africa, began working on a new program. It was launched at Greenville Health System, which cared for more than 450 patients with SCD in 2017. The program features a team of social workers, psychologists, nurses and doctors who provide inpatient and outpatient care, including infusions of pain medications, blood transfusions, education, support and preventive therapy for patients as they grow older.
This improves coordination of care and ensures there are no barriers to care, such as a lack of transportation or insurance. It is based on a model of treatment that combines preventive therapy and a consistent team approach and that’s led to increases in survival. The program also hopes to raise awareness of the disease in the community by working closely with a new Greenville Sickle Cell Disease Community Advisory Board made up of community leaders.
+myBinderRelated Content
-
Blood Transfusions for Sickle Cell DiseaseDuring a blood transfusion, a person (th...
-
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British society for ha...Sickle cell disease (SCD) is a generic t...
-
FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe SCD and Transfusion-Dep...BOSTON & ZUG, Switzerland--(BUSINESS...
-
Gene-Editing Treatment Shows Promise for Sickle Cell DiseaseScientists are seeing promising early re...
-
T-Boz: Vote on Tuesday Like Your Health Depends on ItAs a mother, I know that I have a respon...
-
Sick CellsSick Cells' mission is to elevate the vo...
-
Sickle Cell Patient Receives CRISPR Gene TherapyMany human diseases can be traced back t...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.